Additional risk factors improve mortality prediction for patients hospitalized with influenza pneumonia: a retrospective, single-center case-control study

被引:1
作者
Bai, Yu [1 ,2 ]
Guo, Yiqun [1 ,2 ]
Gu, Li [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Inst Resp Med, Dept Infect Dis & Clin Microbiol, 8 Workers Stadium South Rd, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chao Yang Hosp, 8 Workers Stadium South Rd, Beijing, Peoples R China
关键词
Influenza; Pneumonia; D-dimer; Ferritin; Risk factor; COMMUNITY-ACQUIRED PNEUMONIA; SEVERITY; ADULTS;
D O I
10.1186/s12890-022-02283-6
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundSevere influenza, especially influenza pneumonia, causes large numbers of deaths each year. Some patients who develop severe influenza have no known risk factors. In this study we investigated risk factors for mortality of patients with influenza A-related pneumonia who have different basic conditions. We also evaluated the power of pneumonia severity assessment tools in Chinese patients hospitalized with influenza A-related pneumonia. Together, these results could provide a basis for a screening method that has improved ability for the early identification of critical patients who will have poor prognoses in clinical practice.MethodsThis single-center, retrospective case-control study included 152 adult patients with severe influenza over six influenza seasons. Data for diagnoses and demographics, as well clinical data, laboratory findings, treatment methods, 30-day and 60-day outcomes of the patients were collected. Patients who had any of the risk factors for severe influenza were included in the high-risk group, and those that had no known risk factors were included in the low-risk group.ResultsThe PSI, CURB-65 and PIRO-CAP tools all underestimated the mortality rate of patients hospitalized with influenza A-related pneumonia, and this underestimate was more pronounced for low-risk patients. D-dimer (Odds ratio [OR] = 1.052, 95% confidence interval [CI] 1.001-1.106, p = 0.045) and direct bilirubin (OR = 1.143, 95%CI 1.049-1.246, p = 0.002) were independent risk factors for mortality of patients with influenza A-related pneumonia. When used in combination with ferritin and D-dimer, the area under receiver operator characteristic curve (AUC(ROC)) was 0.851 (95%CI 0.780-0.922, p < 0.001), 0.840 (95%CI 0.763-0.916, p < 0.001) and 0.829 (95%CI 0.748-0.911, p < 0.001) for PSI, CURB-65 and PIRO-CAP, respectively, which was higher than that obtained using PSI, CURB-65 and PIRO-CAP alone.ConclusionsThe findings demonstrate that currently used community-acquired pneumonia (CAP) scoring systems could underestimate the risk of influenza A-related pneumonia mortality. D-dimer was shown to be an independent risk factor of mortality for influenza A-related pneumonia in hospitalized patients, and a combination of D-dimer with ferritin could improve the predictive value of PSI, CURB-65 and PIRO-CAP for adverse prognoses of patients with influenza A-related pneumonia.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Examination of Selected Clinical Factors and Medication Use as Risk Factors for Pneumonia During Stroke Rehabilitation A Case-Control Study
    Marciniak, Christina
    Korutz, Alexander W.
    Lin, Emily
    Roth, Elliot
    Welty, Leah
    Lovell, Linda
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2009, 88 (01) : 30 - 38
  • [42] Outcome prediction value of National Early Warning Score in septic patients with community-acquired pneumonia in emergency department: A single-center retrospective cohort study
    Zhou, Hai-jiang
    Lan, Tian-fei
    Guo, Shu-bin
    WORLD JOURNAL OF EMERGENCY MEDICINE, 2020, 11 (04) : 206 - 215
  • [43] Risk factors for nosocomial pneumonia in a geriatric hospital: A control-case one-center study
    Rothan-Tondeur, M
    Meaume, S
    Girard, L
    Weill-Engerer, SB
    Lancien, E
    Abdelmalak, S
    Rufat, P
    Le Blanche, AF
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (07) : 997 - 1001
  • [44] Risk factors, clinical features, and outcomes of patients with hypertrophic cardiomyopathy complicated by ischemic stroke: A single-center retrospective study
    Lu, Jian-Feng
    Fan, Ze-Xin
    Li, Ying
    Wang, Ze-Yi
    Ma, Lin
    Yuan, Bo-Yi
    Yang, Ting-Ting
    Liu, Pen-Ju
    Liu, Guang-Zhi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [45] Risk factors for childhood pneumonia: a case-control study in a high prevalence area in Indonesia
    Sutriana, Vivi Ninda
    Sitaresmi, Mei Neni
    Wahab, Abdul
    CLINICAL AND EXPERIMENTAL PEDIATRICS, 2021, 64 (11) : 588 - 595
  • [46] Risk factors for morbidity and mortality of bloodstream infection in patients undergoing hemodialysis: A nested case-control study
    Fram D.
    Taminato M.
    Ponzio V.
    Manfredi S.R.
    Grothe C.
    Batista R.E.A.
    Belasco A.
    Barbosa D.
    BMC Research Notes, 7 (1)
  • [47] Risk factors for post-polypectomy bleeding; a retrospective case-control study of a high-volume colonoscopy center
    Eleftheriadis, Dimitrios
    Imalis, Christina
    Gerken, Guido
    Wedemeyer, Heiner
    Duerig, Jan
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (10): : 1475 - 1482
  • [48] Predictors of Discontinuance of Oral Feeding in Patients With Advanced Alzheimer Dementia and Aspiration Pneumonia in Japan A Single-center, Retrospective Observational Study
    Akuzawa, Nobuhiro
    Yoshii, Akihiro
    Ono, Akihiro
    Kuwako, Tomohito
    Osaki, Takashi
    Osawa, Sho
    Jingu, Asuka
    Watanabe, Satoru
    Saito, Ryusei
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2019, 33 (04) : 339 - 345
  • [49] Ventilator management and risk of air leak syndrome in patients with SARS-CoV-2 pneumonia: a single-center, retrospective, observational study
    Nodoka Miyake
    Yutaka Igarashi
    Ryuta Nakae
    Taiki Mizobuchi
    Tomohiko Masuno
    Shoji Yokobori
    BMC Pulmonary Medicine, 23
  • [50] Effects of dosing frequency on the clinical efficacy of ampicillin/sulbactam in Japanese elderly patients with pneumonia: A single-center retrospective observational study
    Suzuki, Tomokazu
    Sugiyama, Erika
    Nozawa, Kenji
    Tajima, Masataka
    Takahashi, Kyoka
    Yoshii, Masayoshi
    Suzuki, Hidenori
    Sato, Vilasinee H.
    Sato, Hitoshi
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (02):